MENLO PARK, Calif. & ALAMEDA, Calif.--(BUSINESS WIRE)--Asterias Biotherapeutics, Inc. and BioTime, Inc. (NYSE MKT: BTX) jointly announced today the closing of the transactions under the Asset ...
BioTime, Inc., a biotechnology company focused on regenerative medicine and blood plasma volume expanders, and its subsidiary, LifeMap Sciences, have released ...
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX), a leader in developing pluripotent stem-cell therapies and other technologies designed to address major unmet medical needs, today ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback